HK Neopharm Limited yog ib qho ntawm feem txhim khu kev qha manufacturers thiab lwm tus neeg ntawm tirzepatide api nyob rau hauv Suav teb, featured los ntawm cov khoom zoo thiab cov nqi zoo. Thov so assured mus yuav tirzepatide api hauv Tshuag ntawm no thiab tau txais cov lus hais los ntawm peb lub hoobkas. Customized xaj yog txais tos.
Tirzepatide API yog lub ntiaj teb thawj zaug -hauv-chav kawm GIP/GLP-1 dual receptor agonist. Raws li API tseem ceeb rau kev tswj glycemic tshiab thiab tswj qhov hnyav, nws muaj tus cim tshwj xeeb CAS 2023788-19-2. Nws muab lub zog tswj ntshav qabzib, txo qhov hnyav hnyav, txhim kho metabolic syndrome, thiab cov txiaj ntsig ntawm lub plawv. Qhov API no yog qhov tseem ceeb rau kev kho mob ntshav qab zib hom 2, rog rog thiab cov teeb meem cuam tshuam, thiab tuav txoj haujlwm tseem ceeb hauv kev lag luam tshuaj thoob ntiaj teb thiab kev tshawb fawb thiab kev tsim kho tshiab.
Technical Specifications
|
Khoom npe |
Tirzepatide API |
|
Synonyms |
CAS 2023788-19-2, Tirzepatide hmoov, Tirzepatide raw khoom |
|
Yam ntxwv |
Dawb rau tawm -dawb crystalline hmoov |
|
CAS Nr |
2023788-19-2 |
|
Assay |
Ntau dua lossis sib npaug li 99% (HPLC, Raws li COA) |
|
Formula |
C225H348N48O68 |
|
Pob |
Pob txheej txheem |
|
Cia |
Khaws ntawm -20 degree |
|
Qauv |
|
Raws li ib tug txhim khu kev qha Tuam Tshoj Tirzepatide tsum, peb koom tes nrog ib tug xov tooj ntawm GMP, FDA thiab CEP certified manufacturers. Peb muab cov tuam txhab kws tshuaj thoob ntiaj teb, cov kws tsim tshuaj tshiab thiab cov chaw tshawb fawb nrog ib qho - nres kev daws teeb meem rau Tirzepatide raw khoom los ntawm cov khoom lag luam ruaj khov, cov txheej txheem ua tau zoo thiab cov kev pabcuam customized, npog tag nrho lub voj voog ntawm R&D kev sim, ntsuas ntsuas - nce thiab kev lag luam ntau lawm.
Cov yam ntxwv ntawm cov khoom
Tirzepatide hmoov yog tsim los ntawm kev sib xyaw ua ke ntawm cov khoom sib xyaw ua ke -theem peptide synthesis, kua-theem purification thiab lyophilization refinement. Peptide sib lawv liag, impurity profile thiab hlau residues yog precisely tswj kom lub purity thiab uniformity ntawm Tirzepatide raw khoom los ntawm qhov chaw. Cov khoom lag luam yog dawb rau tawm-cov hmoov dawb lyophilized nrog cov dej solubility zoo heev thiab rov tsim kho sai, tsim nyog rau kev tsim cov qib siab -kawg npaj xws li txhaj tshuaj, cov koob txhaj tshuaj prefilled thiab cwj mem injectors.
Nws muaj cov nram qab no specifications: HPLC purity Ntau tshaj los yog sib npaug rau 99.0%, tag nrho impurities Tsawg dua los yog sib npaug rau 0.8%, siab tshaj ib impurity Tsawg dua los yog sib npaug rau 0.2%, noo noo tsawg dua los yog sib npaug rau 6.0%, acetate 5.0% -11.0%, peptide cov ntsiab lus ntau dua los yog sib npaug rau 72%; amino acid muaj pes tsawg leeg sib txawv tsawg dua los yog sib npaug rau ± 8%, ua raws li ICH Q7 thiab cov qauv tshuaj loj; endotoxin, microbial txwv thiab sterility raws li kev txhaj tshuaj- qib yuav tsum tau muaj.
Tirzepatide API qhib ob qho tib si GIP thiab GLP-1 txoj hauv kev, ua kom muaj txiaj ntsig zoo ntawm cov piam thaj- nyob ntawm glycemic tswj thiab kev tswj hwm qhov hnyav hauv nruab nrab. Nws muaj ib nrab ntawm - lub neej ntawm kwv yees li 5 hnub, txhawb kev tswj hwm ib lub lim tiam, thiab txhim kho kev ua raws li tus neeg mob.
Tirzepatide hmoov muaj cov khoom sib xws thiab cov dej ntws zoo, nrog D90 Tsawg dua lossis sib npaug li 35μm. Nws tuaj yeem npaj tau sai sai rau hauv kev txhaj tshuaj meej, txhim kho kev tsim khoom thiab ua tiav cov khoom tsim nyog tus nqi. Ntev- cov ntaub ntawv ruaj khov lub sij hawm: khaws cia kaw thiab tiv thaiv lub teeb ntawm -20℃rau 24 lub hlis; reconstituted daws tseem ruaj khov ntawm 2-8℃rau 72 teev, ua tau raws li thoob ntiaj teb logistics thiab cia yuav tsum tau.
Full -Cycle Quality Control and Compliance Assurance
Tag nrho -Chain Traceability Management
Peb siv tag nrho - txheej txheem traceability tswj rau Tirzepatide API los ntawm kev pib cov ntaub ntawv, synthesis, purification, lyophilization, crushing, filling thiab ntim rau cov khoom tiav kev soj ntsuam. Txhua batch tau muab tus lej cim tshwj xeeb, nrog rau kev tsim khoom tiav thiab cov ntaub ntawv soj ntsuam khaws tseg, ua kom tag nrho traceability, rov- kuaj thiab tshuaj xyuas. Txhua qhov khoom xa tuaj suav nrog ua tiav COA, HNMR, LC-MS, HPLC chromatograms, cov khoom tsis huv, cov ntaub ntawv microbiological thiab cov ntaub ntawv ruaj ntseg los txhawb kev sau npe thoob ntiaj teb.
Cov qauv nruj nruj nrog cov kev xav tau thoob ntiaj teb
Tirzepatide API (CAS 2023788-19-2) nruj me ntsis raws li ICH Q7, USP, EP thiab CP cov qauv. Peb ua cov kev ntsuam xyuas zoo xws li HPLC purity, GC residual solvents, elemental impurities, endotoxin, sterility thiab peptide cov ntsiab lus. Cov ntsuas tau zoo tau ua tiav nrog thoob ntiaj teb cov tshuaj pharmacopoeias, pab kev npaj nkag mus rau cov lag luam loj xws li Europe, Tebchaws Meskas, Nyiv, Kaus Lim Qab Teb, Southeast Asia thiab Middle East.
Cov txheej txheem txuas ntxiv thiab kev ua kom zoo
Kev txhawb nqa los ntawm kev txhim kho thev naus laus zis txuas ntxiv ntawm cov chaw koom tes, peb khaws kev ua kom zoo dua qub thiab ua kom huv ntawm Tirzepatide hmoov. Thaum txhim kho purity thiab stability, peb optimize Tirzepatide nqi thiab muab efficiency. Peb tau tsim ib qho kev ua tiav rau kev sib txawv ntawm kev tuav, kev hloov pauv thiab kev tshuaj xyuas txhua xyoo los xyuas kom meej qhov zoo thiab ruaj khov ntawm txhua pawg.
Daim ntawv thov Scenario
Kev kho thiab tiv thaiv kab mob ntshav qab zib hom 2
Tirzepatide API yog qhov nyiam thawj/thib ob- kab raw khoom rau cov neeg laus mob ntshav qab zib hom 2. Nws yog siv los tsim ib zaug - txhaj tshuaj txhua lub lim tiam, xws li monotherapy lossis ua ke nrog metformin thiab SGLT-2 inhibitors. Cov kev tshawb fawb pom tias pawg koob tshuaj 15mg ua tiav qhov siab tshaj plaws HbA1c txo ntawm 2.3%, nrog rau 86.7% ntawm cov neeg mob ncav cuag HbA1c Tsawg dua lossis sib npaug li 6.5%, zoo dua li semaglutide thiab basal insulin. Nws ua tau zoo txhim kho cov ntshav qabzib hloov pauv, txo qhov kev pheej hmoo ntawm cov teeb meem microvascular, thiab muab kev xaiv zoo rau cov neeg mob tsis kho qhov ncauj. Lub caij no, nws tuaj yeem txo qhov kev pheej hmoo ntawm 3 xyoos los ntawm 93% hauv cov neeg mob ntshav qab zib ua ntej rog, muab kev txhawb nqa tseem ceeb rau kev tiv thaiv kab mob metabolic.
Kev tswj qhov hnyav
Tirzepatide API yog siv rau lub sijhawm ntev - tswj qhov hnyav hauv cov neeg laus rog thiab rog rog. Cov kev tshawb fawb pom tau tias cov neeg mob uas tsis yog - cov neeg mob ntshav qab zib rog tau ua tiav qhov hnyav nruab nrab ntawm 20.9% ntawm 72 lub lis piam, nrog rau qhov siab tshaj plaws ntawm 25%, ze rau qhov cuam tshuam ntawm kev phais bariatric; Cov neeg mob Suav pom qhov hnyav poob ntawm 17.5% thiab qhov nruab nrab ntawm lub duav ntawm 18.4cm ntawm 52 lub lis piam. Nws txo LDL -C los ntawm 18.2%, triglycerides los ntawm 26.5% thiab systolic ntshav siab li ntawm 7 mmHg, txo qis kev pheej hmoo ntawm plawv plawv. Nws tsim nyog rau cov neeg uas muaj BMI Ntau dua lossis sib npaug rau 30 lossis Ntau dua lossis sib npaug rau 27 nrog kev sib xyaw. Cov ntaub ntawv kho mob tau lees paub qhov hnyav thiab lub cev rog poob, nrog rau kev txhim kho metabolic ntsuas xws li lub duav ncig, ntshav lipids thiab ntshav siab, ua rau nws yog ib qho khoom siv zoo tshaj plaws rau kev tswj qhov hnyav.
Metabolism-Cov teeb meem cuam tshuam
Tirzepatide hmoov tuaj yeem siv rau hauv kev txhim kho cov txheej txheem tshiab rau cov kab mob metabolic xws li obstructive pw tsaug zog apnea, tsis yog - cawv steatohepatitis thiab siab mob plawv. Ntau Phase II cov ntaub ntawv kho mob qhia tau tias muaj kev txhim kho tseem ceeb hauv cov ntsuas kev kho mob, nthuav dav cov ntawv thov hauv kev kho mob ntev.
Innovative Drug R & D thiab Standard Reference
Tirzepatide API tuaj yeem siv los ua tus qauv siv thiab cov khoom siv los txhawb kev muag tshuaj, tshuaj toxicology, pharmacokinetics, kev tshuaj ntsuam xyuas thiab kev tsim qauv zoo. Nws kuj yog siv nyob rau hauv R & D ntawm ntev - ua peptides, prodrugs, nanoformulations thiab lub qhov ncauj kev xa tshuaj, txhawb kev siv technology breakthroughs nyob rau hauv glycemic tswj thiab tswj qhov hnyav.
Social Media Nrov
Tirzepatide yog cov khoom lag luam uas muaj npe nrov tshaj plaws hauv kev tshaj xov xwm thoob ntiaj teb. Ntawm cov platforms xws li X thiab Instagram, tag nrho cov ntsiab lus pom ntau dua 1.2 billion, nrog ntau dua 500,000 qhov kev paub tseeb tshiab tshaj tawm txog kev poob phaus thiab tswj glycemic ntxiv txhua hli. Cov neeg siv kev txaus siab tseem nyob saum 92%. Cov txiaj ntsig kev ntsuas los ntawm KOLs txawv teb chaws thiab cov kws kho mob bloggers qhia qhov hnyav poob ntawm 12% -18% tom qab 12 lub lis piam ntawm kev siv tsis tu ncua, nrog kev txhim kho glycemic tswj tus nqi. Qhov no tau ua rau muaj zog thiab loj hlob thov rau Tirzepatide raw cov ntaub ntawv thiab tiav formulations, ua rau nws yog ib tug siab -xav tau cov khoom nyob rau hauv lub ntiaj teb no kws tshuaj mov saw.
Ntim thiab thauj
Tirzepatide hmoov yog lub nqus tsev vacuum- kaw hauv chaw muag tshuaj- qib lyophilized vials lossis aluminium foil hnab nrog desiccants thiab tiv thaiv lub teeb, nyob hauv cov dej noo- pov thawj thiab oxidation- tiv taus cov ntim sab nraud. Standard specifications: 100mg, 1g, 10g, 100g, 500g, 1kg. Customized Tirzepatide ntim yog muaj.
Tag nrho cov txheej txheem kev thauj mus los siv cov hlua txias lossis - qhov kub thiab txias - cov ntaub ntawv pov thawj nrog rau - lub sijhawm ntsuas kub. Kev faib tawm hauv tsev yog tswj hwm los ntawm cov tuam txhab kws tshuaj logistics; Kev thauj mus los thoob ntiaj teb ua raws li UN thiab IATA cov kev cai, muab kev pabcuam huab cua, dej hiav txwv thiab thoob ntiaj teb nrog kev taug qab thiab kev lis kev cai zoo.
Peb Qhov Zoo
Muaj peev xwm ruaj khov thiab nyob rau hauv -Tshuaj lav
Peb muaj ntev - daim ntawv cog lus muab khoom nrog rau GMP cov chaw. Tirzepatide hauv Tshuag txhawb rau kev txiav txim sai. R & D sim txiav txim pib los ntawm 100mg, thiab kev lag luam ntau lawm txhawb nqa ntau Tirzepatide kev yuav khoom kom tsis txhob ncua sijhawm R&D thiab ntau lawm.
Hwm zoo thiab kev them nyiaj yug rau npe
Cov khoom yog tsim nyob rau hauv GMP / FDA / CEP certified chaw. Tirzepatide API purity yog ntau dua los yog sib npaug rau 99.0%, tshaj thoob ntiaj teb cov qauv tshuaj pharmacopoeia. Peb muab cov ntaub ntawv sau npe ua tiav los txhawb nqa cov ntaub ntawv thoob ntiaj teb.
Pob tshab thiab tsim nyog Tirzepatide Nqe
Loj - nplai ntau lawm thiab cov khoom lag luam ruaj khov ua kom muaj txiaj ntsig zoo, pab cov neeg siv khoom tswj cov nqi. Cov nqi qhib thiab pob tshab uas tsis muaj tus nqi zais.
Mature Ntiaj Teb Export thiab Kev Pabcuam
Peb muaj cov tshuab ua tiav rau kev tshaj tawm kev lis kev cai, tshuaj xyuas, kev xa khoom thiab cov ntaub ntawv, nrog rau kev muag khoom mus rau ntau tshaj 60 lub teb chaws thoob ntiaj teb. Peb muab 7 × 12 teev kev txhawb nqa ntau yam lus, kev pab cuam thiab sai tom qab- kev muag khoom.
Saj zawg zog Customization Services
Peb muab cov kev pabcuam Tirzepatide customized, nrog kho purity, particle loj, noo noo cov ntsiab lus, ntim specifications thiab ntau ntxiv kom tau raws li tshwj xeeb formulation thiab R & D yuav tsum tau.
FAQ
Cim npe nrov: Tuam Tshoj tirzepatide API manufacturers, lwm tus neeg, Hoobkas
